TGFB1 and breast carcinoma: Recent evidence has shown that the inhibitory effect of HTyr in regulating breast cancer cell migration and invasion is dependent on its ability to target EMT, Wnt/β-catenin, and transforming growth factor-β (TGF-β) pathways [105].